Cure4 Cystic Fibrosis Foundation
In 2018 the Cure4 Cystic Fibrosis Foundation (C4CF) made a strategic decision to partner with the National Foundation for Medical Research and Innovation (NFMRI) to manage and administer grants on their behalf with the first call for expressions of interest commencing in 2019.
The partnership will provide at least $750K to advance medical innovations in the area of cystic fibrosis over the next three years and will be named the Cure4 Cystic Fibrosis Foundation – Barbara Stow-Smith CF Innovation Grant‘, in honour of the Foundation’s first bequest.
Utilising NFMRI’s successful strategy, and unique capability and capacity the partnership will fund research that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life.
Executive Manager, Suzy Dimaline said‘A partnership with NFRMI allows Cure4 Cystic Fibrosis to expand its grant program to the national scientific research community. The expert assessment of the Research Advisory Committee and the broad reach of the NFMRI grant program to universities and medical research institutes across Australia, means that Cure4 Cystic Fibrosis can achieve a long-desired ambition to fund the best CF research initiatives across the country. NFMRI’s focus on translation and collaboration is key to producing outcomes that will benefit the cystic fibrosis community and we look forward to sharing learnings with our supporters and partners.’
Expressions of interest will be called in three key gap areas known as social investment portfolios. Priority will be given to portfolios two and three that focus on critical translational research activities accessing external research collaborations and capabilities to undertake critical research studies. For more information about the portfolio’s please visit https://nfmri.org.au/research-and-innovation/portfolio-summary/
The second special purpose grant round will be held in early 2020 to seek proposals specific to Cystic Fibrosis that align with NFMRI’s strategy and mission. To find out more about these funding opportunities, please subscribe to our newsletter here.